Another potent and selective cathepsin B inhibitor, CA-074, when administered as a prodrug (CA-074Me) in mice genetically modified for AD, causes memory improvement and reduces Aβ(1–40) and Aβ(1–42) in the brain [44]. Here, CTSB is linked to Alzheimer disease.